glp-1-ras The Impact of GLP-1 Receptor Agonists on Ocular Disease Researchers issue a warning that
Description
Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.
Experience the power of a glp1 probiotic that Reclaim control over your eating habits with a formulation that promotes fullness and satisfaction
A new FDA-approved obesity pill could offer a lower-cost alternative to injectable GLP-1 drugs like Ozempic and Mounjaro
Pendulum Glucose Control
Probiotics promote gut and digestive health, which play a role in overall wellness.*
